Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
Abstract Background Alzheimer’s disease (AD) is a neurodegenerative disorder that manifests sequential Aβ and tau brain pathology with age-dependent onset. Variants in the microglial immune receptor TREM2 are associated with enhanced risk of onset in sporadic Alzheimer’s disease (AD). While recent s...
Main Authors: | Bing Zhu, Yan Liu, Spring Hwang, Kailey Archuleta, Huijie Huang, Alex Campos, Rabi Murad, Juan Piña-Crespo, Huaxi Xu, Timothy Y. Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | Molecular Neurodegeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13024-022-00562-8 |
Similar Items
-
TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo
by: Audrey Lee-Gosselin, et al.
Published: (2023-06-01) -
The role of TREM2 in Alzheimer’s disease: from the perspective of Tau
by: Wendi Huang, et al.
Published: (2023-11-01) -
Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
by: Michael Ewers, et al.
Published: (2020-09-01) -
The prion-like transmission of tau oligomers via exosomes
by: Noel A. Jackson, et al.
Published: (2022-08-01) -
Tangles, toxicity, and tau secretion in AD – new approaches to a vexing problem
by: Kerry eGendreau, et al.
Published: (2013-10-01)